Cyberkinetics Neurotechnology Systems, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by OXFORD BIOSCIENCE PARTNERS IV LP, was filed 20 Oct 2006.
Cyberkinetics Neurotechnology Systems, Inc.: what insiders have been doing
Cyberkinetics Neurotechnology Systems, Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). No insider at Cyberkinetics Neurotechnology Systems, Inc. has published a filing in the past twelve months. The most recent one dates from 20 June 2008.
Over the whole record (from 2006), the tally stands at 2 purchases and no sales.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
- 2,382,500 shares@ US$0.10Common StockSEC:0001144204-08-036181:0
- 1,000,000 shares@ US$0.10Common StockSEC:0001144204-08-036182:0
- 75,000 shares0Common StockSEC:0001144204-07-062882:0
- 100,000 shares0Common StockSEC:0001144204-07-062575:0
- 45,000 shares0Common StockSEC:0001144204-07-062595:0
- 165,000 shares0Common StockSEC:0001144204-07-062573:0
- 75,000 shares0Common StockSEC:0001144204-07-062577:0
- 10,000 shares@ US$1.13Common StockSEC:0001144204-07-011333:0
- 8,297 shares@ US$1.13Common StockSEC:0001144204-07-011337:0
- 9,126 shares@ US$1.13Common StockSEC:0001144204-07-011345:0
- 825,056 shares@ US$1.20Common StockSEC:0001012975-06-000417:0Canonical exit: 16 Jan 2007 (T+90)
- 8,278 shares@ US$1.20Common StockSEC:0001012975-06-000417:1Canonical exit: 16 Jan 2007 (T+90)
- 100,000 shares@ US$1.58Common StockSEC:0001209191-06-051038:0
- 3,870 shares0Common StockSEC:0001209191-06-003203:2
- 3,871 shares0Common StockSEC:0001209191-06-003203:3
- 3,870 shares0Common StockSEC:0001209191-06-003203:4
- 3,870 shares0Common StockSEC:0001209191-06-003203:5
- 3,871 shares0Common StockSEC:0001209191-06-003203:0
- 3,870 shares0Common StockSEC:0001209191-06-003203:1
19 of 19 declarations
About Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics Neurotechnology Systems, Inc. is a company focused on developing neurotechnology solutions. It aims to create innovative products to enhance the quality of life for individuals with neurological disorders.
